6Yokoyama H, Wada T, Furuichi K. Immunomodulation effects and clinical evidence of apheresis in renal diseases[J]. Ther Apher Dial, 2003, 7:497. 被引量:1
7Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE[J]. Arthritis Rheum, 1992,35:630 640. 被引量:1
8Hershko AY, Naparstek Y. Removal of pathogenic autoanti- bodies by immunoadsorption[J]. Ann N Y Acad Sci, 2005, 1051:635-646. 被引量:1
9Yokoyama H, Wada T, Furuichi K. Immunomodulation effects and clinical evidence of apheresis in renal diseases[J]. Ther Apher Dial, 2003,7:513-519. 被引量:1
10Griveas I, Sourgounis A, Visvardis G, et al. Immunoadsorption in lupus myocarditis[J]. Ther Apher Dial, 2004,8:281-285. 被引量:1